Daniel P. Leaman

974 total citations
18 papers, 567 citations indexed

About

Daniel P. Leaman is a scholar working on Virology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Daniel P. Leaman has authored 18 papers receiving a total of 567 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Virology, 9 papers in Immunology and 8 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Daniel P. Leaman's work include HIV Research and Treatment (18 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Immune Cell Function and Interaction (8 papers). Daniel P. Leaman is often cited by papers focused on HIV Research and Treatment (18 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Immune Cell Function and Interaction (8 papers). Daniel P. Leaman collaborates with scholars based in United States, United Kingdom and Spain. Daniel P. Leaman's co-authors include Michael B. Zwick, Arthur S. Kim, Dennis R. Burton, Erin M. Scherer, Andrew J. McMichael, Lei Zhang, Jeong Hyun Lee, Andrew B. Ward, Johannes S. Gach and Edgar A. Hodge and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Nature Communications.

In The Last Decade

Daniel P. Leaman

18 papers receiving 561 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel P. Leaman United States 14 459 246 223 200 165 18 567
Karen L. Saye-Francisco United States 9 476 1.0× 273 1.1× 266 1.2× 273 1.4× 167 1.0× 10 670
Jonathan Stuckey United States 5 482 1.1× 233 0.9× 190 0.9× 165 0.8× 240 1.5× 6 555
Viktoriya Dubrovskaya United States 9 394 0.9× 257 1.0× 218 1.0× 201 1.0× 97 0.6× 13 522
Jeffrey Copps United States 12 248 0.5× 256 1.0× 117 0.5× 121 0.6× 194 1.2× 24 511
Leo Laub United States 4 570 1.2× 197 0.8× 341 1.5× 243 1.2× 222 1.3× 5 743
Yuuei Shu United States 8 401 0.9× 149 0.6× 264 1.2× 229 1.1× 136 0.8× 8 502
Christopher Gu United States 10 571 1.2× 212 0.9× 214 1.0× 125 0.6× 356 2.2× 17 695
Peter Bouma United States 11 316 0.7× 128 0.5× 197 0.9× 163 0.8× 178 1.1× 11 486
Aemro Kassa United States 9 509 1.1× 147 0.6× 216 1.0× 141 0.7× 325 2.0× 10 598
Maphuti Madiga South Africa 6 489 1.1× 140 0.6× 295 1.3× 116 0.6× 204 1.2× 9 569

Countries citing papers authored by Daniel P. Leaman

Since Specialization
Citations

This map shows the geographic impact of Daniel P. Leaman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel P. Leaman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel P. Leaman more than expected).

Fields of papers citing papers by Daniel P. Leaman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel P. Leaman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel P. Leaman. The network helps show where Daniel P. Leaman may publish in the future.

Co-authorship network of co-authors of Daniel P. Leaman

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel P. Leaman. A scholar is included among the top collaborators of Daniel P. Leaman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel P. Leaman. Daniel P. Leaman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Leaman, Daniel P., Rene Yu-Hong Cheng, Iram Khan, et al.. (2023). A lentiviral vector B cell gene therapy platform for the delivery of the anti-HIV-1 eCD4-Ig-knob-in-hole-reversed immunoadhesin. Molecular Therapy — Methods & Clinical Development. 28. 366–384. 7 indexed citations
2.
Prasad, Vidya Mangala, Daniel P. Leaman, Klaus N. Lovendahl, et al.. (2022). Cryo-ET of Env on intact HIV virions reveals structural variation and positioning on the Gag lattice. Cell. 185(4). 641–653.e17. 55 indexed citations
3.
Rujas, Edurne, Daniel P. Leaman, Pablo Carravilla, et al.. (2021). Focal accumulation of aromaticity at the CDRH3 loop mitigates 4E10 polyreactivity without altering its HIV neutralization profile. iScience. 24(9). 102987–102987. 3 indexed citations
4.
Leaman, Daniel P., et al.. (2021). Membrane Env Liposomes Facilitate Immunization with Multivalent Full-Length HIV Spikes. Journal of Virology. 95(13). e0000521–e0000521. 5 indexed citations
5.
Rujas, Edurne, Daniel P. Leaman, Pablo Carravilla, et al.. (2020). Affinity for the Interface Underpins Potency of Antibodies Operating In Membrane Environments. Cell Reports. 32(7). 108037–108037. 12 indexed citations
6.
Rujas, Edurne, et al.. (2018). Functional Optimization of Broadly Neutralizing HIV-1 Antibody 10E8 by Promotion of Membrane Interactions. Journal of Virology. 92(8). 21 indexed citations
7.
Stano, Armando, Daniel P. Leaman, Arthur S. Kim, et al.. (2017). Dense Array of Spikes on HIV-1 Virion Particles. Journal of Virology. 91(14). 49 indexed citations
8.
Leaman, Daniel P., et al.. (2017). Functional Stability of HIV-1 Envelope Trimer Affects Accessibility to Broadly Neutralizing Antibodies at Its Apex. Journal of Virology. 91(24). 17 indexed citations
9.
Lee, Jeong Hyun, Daniel P. Leaman, Arthur S. Kim, et al.. (2015). Antibodies to a conformational epitope on gp41 neutralize HIV-1 by destabilizing the Env spike. Nature Communications. 6(1). 8167–8167. 65 indexed citations
10.
Leaman, Daniel P., Jeong Hyun Lee, Andrew B. Ward, & Michael B. Zwick. (2015). Immunogenic Display of Purified Chemically Cross-Linked HIV-1 Spikes. Journal of Virology. 89(13). 6725–6745. 21 indexed citations
11.
Kim, Arthur S., Daniel P. Leaman, & Michael B. Zwick. (2014). Antibody to gp41 MPER Alters Functional Properties of HIV-1 Env without Complete Neutralization. PLoS Pathogens. 10(7). e1004271–e1004271. 44 indexed citations
12.
Narayan, Kristin, Daniel P. Leaman, Pham Phung, et al.. (2013). Prime-Boost Immunization of Rabbits with HIV-1 gp120 Elicits Potent Neutralization Activity against a Primary Viral Isolate. PLoS ONE. 8(1). e52732–e52732. 14 indexed citations
13.
Leaman, Daniel P. & Michael B. Zwick. (2013). Increased Functional Stability and Homogeneity of Viral Envelope Spikes through Directed Evolution. PLoS Pathogens. 9(2). e1003184–e1003184. 41 indexed citations
14.
Leaman, Daniel P., et al.. (2011). Functional Stability of Unliganded Envelope Glycoprotein Spikes among Isolates of Human Immunodeficiency Virus Type 1 (HIV-1). PLoS ONE. 6(6). e21339–e21339. 30 indexed citations
15.
Gach, Johannes S., Daniel P. Leaman, & Michael B. Zwick. (2011). Targeting HIV-1 gp41 in Close Proximity to the Membrane Using Antibody and Other Molecules. Current Topics in Medicinal Chemistry. 11(24). 2997–3021. 23 indexed citations
16.
Leaman, Daniel P., et al.. (2010). In-Solution Virus Capture Assay Helps Deconstruct Heterogeneous Antibody Recognition of Human Immunodeficiency Virus Type 1. Journal of Virology. 84(7). 3382–3395. 44 indexed citations
17.
Murray, Edward J., Daniel P. Leaman, Chris Pickford, et al.. (2010). A Low-Molecular-Weight Entry Inhibitor of both CCR5- and CXCR4-Tropic Strains of Human Immunodeficiency Virus Type 1 Targets a Novel Site on gp41. Journal of Virology. 84(14). 7288–7299. 24 indexed citations
18.
Scherer, Erin M., Daniel P. Leaman, Michael B. Zwick, Andrew J. McMichael, & Dennis R. Burton. (2010). Aromatic residues at the edge of the antibody combining site facilitate viral glycoprotein recognition through membrane interactions. Proceedings of the National Academy of Sciences. 107(4). 1529–1534. 92 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026